Tolerx
A company developing therapies modulatng T-cell activities to treat autoimmune diseases, diabetes and cancer
1
Funding Rounds
$1.5m
Money raised
Funding series
Funding Series Analysis
The company Tolerx has raised a total of $1.5m in funding over 1 rounds.
Key Insights:
- Tolerx funding round, December 2010: $1.5m
Tolerx funding round, December 2010
$1.5m
Industries
Tolerx is active in the following industries: